Talk:Indiana Biosciences Research Institute

Ibricommsdirector
I understand I may have a conflict of interest as I am the director of communications and engagement at the Indiana Bioscience Research Institute. I simply endeavor to update the entry to align with our current strategy and updated website that clearly identifies current board members, etc. Ibricommsdirector (talk) 15:51, 2 August 2022 (UTC)


 * Please change opening short description to align with this organization's current strategy as reflected on its website, www.indianabiosciences.org.
 * A more appropriate short description might read, "The Indiana Biosciences Research Institute (IBRI) is an American nonprofit headquartered in Indianapolis, Indiana, within the 16 Tech Innovation District. The IBRI is a leading translational research institute that advances academic and industry science through collaboration to improve patient health outcomes. Its primary focus is on better understanding the pathogenesis of type 1 and type 2 diabetes. Its goal is to translate this knowledge into novel therapies, while also looking to expand into other diseases that share common systems and pathways." Ibricommsdirector (talk) 16:05, 2 August 2022 (UTC)
 * Please add other social media channels to the external links.
 * IBRI on LinkedIn - https://www.linkedin.com/company/indiana-biosciences-research-institute
 * IBRI on Instagram - https://www.instagram.com/inbiosciences/
 * IBRI on Facebook - https://www.facebook.com/INBiosciences/ Ibricommsdirector (talk) 16:12, 2 August 2022 (UTC)
 * Please remove the IBRI Scientific Advisory Board list as the organization no longer uses this board. Ibricommsdirector (talk) 16:16, 2 August 2022 (UTC)
 * Please update the IBRI's Board of Directors to reflect the current list that includes:
 * Robert Bernhard, University of Notre Dame
 * Wayne Burris, Roche Diagnostics Corporation
 * Kenneth Custer, Eli Lilly and Company
 * Daniel Evans, Jr., Indiana University Health
 * Tatiana Foroud, Indiana University School of Medicine
 * Jay Hess, Indiana University
 * David Ingram, Indiana University Health
 * Cris Johnston, Indiana Office of Management and Budget
 * John Lechleiter, Eli Lilly and Company
 * Patricia Martin, BioCrossroads, Inc.
 * Theresa Mayer, Purdue University
 * Hany Moselhi, Roche Diagnostics North America
 * Alan Palkowitz, Indiana Biosciences Research Institute
 * Dan Peterson, Cook Group, Inc.
 * Aaron Schacht, BiomEdit, LLC
 * Wendy Srnic, Corteva Agriscience
 * Bill Stephan, Indiana University Ibricommsdirector (talk) 16:21, 2 August 2022 (UTC)